Research News

Crack GPAT — Prepare for GPAT Online 
  • High blood pressure associated with environmental contamination by tellurium
    6 August 2024

    High blood pressure associated with environmental contamination by tellurium

    The likelihood of developing high blood pressure increases with higher levels of tellurium, a contaminant transferred from mining and manufacturing activities to foods. Improved monitoring of tellurium levels in specific foods could help decrease high blood pressure in the general population. The results of a study examining the relationship between tellurium exposure and hypertension were published in the journal Environment International.
  • 2 August 2024
    AI Opens Door to Safe, Effective New Antibiotics to Combat Resistant Bacteria
    In a hopeful sign for safe, effective antibiotics for humans, researchers at The University of Texas at Austin have leveraged aritificial intelligence to develop a new drug that already is showing promise in animal trials. Publishing their results today in Nature Biomedical Engineering, the scientists describe using a large language model an AI tool like the one that powers ChatGPT to engineer a version of a bacteria-killing drug that was previously toxic in humans, so that it would be safe to use.
  • 31 July 2024
    The virus that causes COVID-19 is widespread in wildlife : Scientists find

    SARS-CoV-2, the virus responsible for COVID-19, is widespread among wildlife species, according to Virginia Tech research published today in Nature Communications. The virus was detected in six common backyard species and antibodies indicating prior exposure to the virus were found in five species with rates of exposure ranging from 40 to 60 percent depending on the species.

  • 31 July 2024
    Improving the Design of mRNA-loaded Nanocarriers for Targeted Therapies

    Substituting amines with phosphonium-based cations could greatly improve the performance of mRNA-loaded polymeric micelles, report scientists from Tokyo Tech. By adopting this innovative strategy, they managed to enhance the stability and mRNA-delivery capabilities of micelle nanocarriers into tumor tissue in vivo. Their results hint at the importance of exploring other cations besides amines in mRNA drug delivery and could pave the way to effective treatment for challenging diseases.

  • 25 July 2024
    Large genetic study on severe COVID-19 - Bonn researchers confirm three other genes for increased risk in addition to the known TLR7 gene
    Whether or not a person becomes seriously ill with COVID-19 depends, among other things, on genetic factors. With this in mind, researchers from the University Hospital Bonn UKB and the University of Bonn, in cooperation with other research teams from Germany, the Netherlands, Spain and Italy, investigated a particularly large group of affected individuals.
  • 25 July 2024
    Fighting leukaemia by targeting its stem cells
    Acute myeloid leukaemia is one of the deadliest cancers. Leukaemic stem cells responsible for the disease are highly resistant to treatment. A team from the University of Geneva UNIGE, University Hospital of Geneva HUG, and Inserm has made a breakthrough by identifying some of the genetic and energetic characteristics of these stem cells, notably a specific iron utilisation process.
  • 23 July 2024
    These healthcare professionals may be secret weapon against hypertension, study finds

    When it comes to helping patients with high blood pressure get their hypertension under control, a new Tulane University study finds that pharmacists and community health workers have the best success rates.

  • 18 July 2024
    Diabetes Drug Reduces Drug Resistance in Lung Cancer
    A medication used to treat diabetic neuropathy may make chemotherapy treatments more effective for patients with lung cancer, according to new findings from the University of Missouri School of Medicine published in Clinical Cancer Research, a journal of the American Association for Cancer Research.
  • 18 July 2024
    New gene therapy for muscular dystrophy offers hope
    A new gene therapy treatment for Duchenne muscular dystrophy shows promise of not only arresting the decline of the muscles of those affected by this inherited genetic disease, but perhaps, in the future, repairing those muscles.
  • 17 July 2024
    Supplements slow disease progression during late stage of dry age-related macular degeneration
    In a new analysis of data, researchers at the National Institutes of Health (NIH) have found that taking a daily supplement containing antioxidant vitamins and minerals slows progression of late-stage dry age-related macular degeneration (AMD), potentially helping people with late-stage disease preserve their central vision. Researchers reviewed the original retinal scans of participants in the Age-Related Eye Diseases Studies (AREDS and AREDS2) and found that
Subscribe to Research News